Viridian Therapeutics Inc
VRDN
$14.68+0.44 (+3.09%)
Jun 7, 2025, 4:00 PM
Financials
| 52Week High | 27.20 | 52Week Low | 9.90 |
| Beta | 0.48 | Current Ratio Annual | 15.43 |
| Current Ratio Quarterly | 19.49 | Gross Margin TTM | 2.36 |
| Market Cap | 1.20B | Net Profit Margin TTM | -102,092.38 |
| Operating Margin TTM | -111,591.06 | Price To Book | 1.98 |
| Price To Sales TTM | 3,966.13 | Quick Ratio Annual | 14.99 |
| Quick Ratio Quarterly | 18.88 | Return On Assets TTM | -44.67 |
| Return On Equity TTM | -49.08 | Return On Investment TTM | -47.52 |
| Revenue Growth3Y | -53.27 | Revenue Growth5Y | -41.64 |
| Revenue Growth Quarterly Yoy | 0.00 | Revenue Growth TTMYoy | 6.34 |
| Revenue Per Share TTM | 0.00 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 182 | 1 | 1 | 5 | 3 | 0 | 92.44M | $1.70B |
| Mar 31, 2025 | 179 | 22 | 27 | 64 | 59 | 28 | 91.50M | $1.19B |
| Change | 3(2%) | 21(2100%) | 26(2600%) | 59(1180%) | 56(1867%) | 28 | 936.18K(1%) | $511.12M(30%) |